All Articles

Inter-CFAR Fellowship Program in Implementation Science (2022-2023)

On behalf of inter-CFAR Implementation Science Working Group and the Mid-Atlantic CFAR Implementation Science Hub, we are welcoming applications for an NIH-funded training opportunity in implementation science (IS) for early stage investigators (ESIs) engaging in HIV-related research. Since its inaugural class of 2019-2020, the fellowship has engaged 81 fellows in the program. This year’s Implementation Science Fellows will be selected across the CFAR network, HBCUs and U.S.

The Duke CFAR celebrates Pride Month

As the nation recognizes Pride Month this June, the Duke CFAR re-affirms our commitment to celebrating and supporting the lesbian, gay, bisexual, transgender, and queer (LGBTQ+) community in our day-to-day lives, our interactions with colleagues, patients, and community, and throughout our research mission.

PrEP in 2022: What's New in the Guidelines? A webinar by Christopher Hurt, MD, FIDSA

This one-hour webinar will cover key changes in the management of HIV pre-exposure prophylaxis (PrEP) for the United States, following the issuance of the most recent CDC/USPHS PrEP Guideline update in December 2021. Participants will learn about the evidence base behind the changes and where to find resources to help support the implementation of updated recommendations. The speaker, Dr. Christopher Hurt from the UNC School of Medicine, has been working to help providers implement PrEP in North Carolina since 2014 and is an expert on PrEP service delivery.

Early Career Investigator Resources from the NIH Office of AIDS Research

We are pleased to announce the launch of a new resource for Early Career Investigators from the NIH Office of AIDS Research (OAR) intended to centralize relevant information for investigators and provide easy access to grant opportunities, basic information, and other resources, such as training and capacity building programs.

Global Equity During Pandemics: Lessons from HIV and COVID for Designing a New Paradigm

Ongoing global Covid-19 vaccine and therapeutic inequities threaten to prolong and exacerbate the pandemic for all countries. As advocates, academics, and policymakers alike call for the U.S. and other wealthy nations to share these lifesaving resources with the world, it is prudent to consider the lessons learned from the HIV pandemic that can be translated into this current moment.